GENinCode, WaterBear, Avacta, Maxcyte, Verici.
Key Sector Experience
Biotechnology, Energy, Technology
Stella is based in London and is responsible for new growth capital investments and Maven’s AIM Portfolio. Having joined Aberdeen Asset Management in 2005, Stella now leads the Maven AIM team in London as well as sourcing plus supporting private equity across the firm.
Prior to joining AAM, Stella was a corporate finance executive for three years at Seymour Pierce, where she advised companies listing on AIM and managed a VCT. She has also previously worked for Pricewaterhouse Coopers, The World Bank and Raifessen Investment Fund.
Stella has a degree in Economics and an MA in Applied Economics.
Outside of work, Stella is keen on classical theatre and music as well as keeping up to date with current affairs, with a particular interest in politics. Stella also is keenly involved with her social network around the City. Stella finds the greatest joy in spending time with her family.
Most days, I get to see innovative and passionate management teams either present a new concept or provide an update on the hard work they have been undertaking. Each new investment represents the opportunity to guide and support management through their development, or to support the team through new challenges and negotiations. By supporting teams who advance technology, we create value on behalf of our shareholders. To back disruptors at the forefront of healthcare, green energy and novel technology is a great privilege and an opportunity to get behind the next generation of leaders and ahead of major, evolving markets.
Meet our other team members
With a network of ten offices and a national investment team, including professionals from a variety of commercial, financial and industry backgrounds, we have an enhanced regional presence giving us a different perspective to many other funders.